Pharmaceutical company Astex has entered an exclusive worldwide research agreement with Genentech to identify treatments for breast cancer. The partnership will aim to find small molecule drug candidates with selective inhibitory activity as potential treatments for breast cancer, leveraging Astex’s fragment-based drug discovery programme. Under the terms of… Read More
The latest episode of the DDW ‘In Conversation With’ series is available to listen to below. This week, Bruno Quinney speaks to Suzanne Caruso, President of Strategic Intelligence and Clinical & Regulatory at Norstella. Norstella supports drug developers looking to take their treatments from pipeline to patients, finding solutions to complexities… Read More
Health technology company myTomorrows has secured $29 million in funding to develop its AI-driven global platform, aiming to bring patients access to innovative therapies. The company aims to develop a platform to bridge the gap between scientific advancement and patient access to pre-approval treatments. This includes drug… Read More
Pharmaceutical company Lumosa Therapeutics has announced positive results from its Phase IIb clinical trial of LT3001 in patients with acute ischaemic stroke. LT3001 met its primary endpoint of safety, with no treatment-related symptomatic intracranial haemorrhage (siCH) observed. The results showed that LT3001 maintained a favourable safety profile… Read More
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Emma Johnson, CEO… Read More
DDW’s Megan Thomas speaks with Dr Jennifer Bradford, VP, Head of Data Science at Coronado Research, about the impact of artificial intelligence (AI) on the clinical development process, how to overcome common barriers to adoption and the developments with the potential to accelerate innovation. MT: How do you envision AI… Read More
This is the latest episode of the free DDW narrated podcast, titled “Revolutionary technology for drug discovery and development” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: mRNA technology may hold the future for a cytomegalovirus vaccine; … Read More
Fosun Pharma USA and Treehill Partners have formed a jointly operating vehicle for investment in clinical stage assets. The new business will be looking for high-quality, mid- to late-stage assets, clinically focused on the US market. There will also be a focus on high quality non-US clinical… Read More
Dr Asma Patel, Vice President of Integrated Services for Early Development at Quotient Sciences, reflects on the biggest barriers to rare disease drug development and how companies can overcome these. Despite improvements in regulatory support and commercial rewards, difficulties remain for drug developers in bringing rare disease drugs… Read More
Listen to this article on the DDW podcast: Allison August, M.D., Vice President, Clinical Development, Infectious Diseases at Moderna examines the data on cytomegalovirus (CMV), why attempts at vaccines for CMV have so far proved elusive and the emerging options to address this unmet need. … Read More
Solutions provider SMC Ltd has opened a new business offering pharmaceutical development services at the Cambridge Research Park in the UK. Cambridge Pharma offers pharmaceutical development services, including sterile fill-finish and launches with a 20,000 sq. ft facility offering a range of manufacturing services for clinical trial… Read More
This 28-page DDW eBook, sponsored by Bio IVT, contains exclusive insight from industry experts on: Cell & gene therapies: the challenges and trends Battling the bottleneck: leveraging education to close the advanced therapy talent gap Cell and gene therapies: Opportunities for innovation Informing strategic decision-making in early clinical development… Read More
